Skip to content

pharmaceuticals.co.nz

Drugs, medicines and medical news
Main navigation

Month: April 2022

MPs reject amendment that would require proper workforce planning

The government continues to reject attempts to make parliament accountable for NHS workforce planning.This week MPs voted against […]

April 26, 2022 Uncategorized

Molnupiravir might be dangerous without clarification of its indications

The data on which the approval of molnupiravir was based in Japan1 and the data reported by Bernal […]

April 26, 2022 COVID-19

Will obtaining digital consent from patients in advance of undergoing procedures improve the quality of the consent process?

I’m due to be taken to the cardiac catheter theatre this morning. Yesterday evening, a scan showed a […]

April 26, 2022 Uncategorized

Untapping the hidden value of clinical trial registries

Systematic reviews provide a summary of all relevant evidence on a research topic. Since around 50% of biomedical […]

April 26, 2022 Uncategorized

The Steve Morgan Foundation donates £50m to diabetes research

The Foundation also launched a new collaboration with Diabetes UK and the Juvenile Diabetes Research Foundation UK

April 26, 2022 Uncategorized

ViGeneron and Daiichi Sankyo to develop therapy for eye diseases

Follow-on collaboration between ViGeneron and Daiichi Sankyo allows the companies to create and validate vgAAV-based therapeutic candidates

April 26, 2022 Uncategorized

New graphite based rapid sensor chip for real-time theophylline monitoring

Although theophylline (THO) is effective in treating respiratory problems and inflammation, the drug can be toxic if taken […]

April 26, 2022 Uncategorized

The impact of COVID-19 on drug use — and how it contributes to overdose risk

In rural communities, structural and community factors during the pandemic have increased anxiety, depression, and loneliness and altered […]

April 26, 2022 Uncategorized

Helen Salisbury: Fallout from the rise in private referrals

When I started out in general practice I made very few referrals to consultants working outside the NHS. […]

April 26, 2022 General practice / family medicine, UK

Molnupiravir’s authorisation should be re-evaluated after the Panoramic trial is reported

Brophy’s editorial on Merck’s Move-Out trial of molnupiravir raises important concerns about the approval of molnupiravir to treat […]

April 26, 2022 COVID-19

Posts navigation

Posts pagination

« Previous 1 … 4 5 6 … 26 Next »
Proudly powered by WordPress | Theme: Hive Lite by Pixelgrade.
Footer navigation
  • Privacy Policy